Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
BABE : Essential Innovation in Public and Medical Health
- BABE Congress 2019

Welcome Message

We welcome you all across the world to attend the World Congress On Bioavailability, Bioequivalence and Business Management which is going to be held on December 09-10, 2019 at Abu Dhabi, UAE which includes prompt keynote presentations, Poster presentations, oral talks and Exhibitions. We cordially invite all Clinical & Medical Experts who are interested in sharing their research experience and practical knowledge in the arena of clinical and medical science.
BABE Congress 2019 aims to gather all the Researchers, principal investigators, experts and researchers working under academia and healthcare industry, Business Delegates, Scientists and students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.
This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Speakers at our BABE Congress 2019 to talk about new advances in the field of both medical and engineering to improve health and treatment and also additional innovations. We hope that you will grasp this academic occasion to revitalize the enduring connections and flash with new peers around the globe.

Abstract Submission

Abstract Submission Guidelines:

The length of the abstract must not exceed 300 words.
The title should be in Sentence case.
Should write name of the author and co-authors (if any).
You must provide your full name, affiliation (degree, institution/ company/ University name, address,contact  number and email address).
Short biography of the author (limited to 100 words).
They must be submitted before the deadlines.
All the abstracts will be reviewed by the committee and you will get a email within 24-48 hours after submission of your abstract.
All the accepted abstracts will be published in the conference proceeding books.

Abstract Submission Linkhttp://bioavailability-bioequivalence.alliedacademies.com/abstract-submission

The Young Researchers Forum offers young researchers the possibility to meet and discuss research topics and methodologies, share and develop ideas, learn from each other and gain knowledge from senior researchers.
Young Researcher Sessions are organized at the World Congress On Bioavailability & Bioequivalence, to provide a unique platform for Young Researches/Investigators for presenting the latest research projects with an in-depth analysis. Allied Academies cordially invites Young Researchers from Universities/Institutes/Industries to present a short oral presentation during the forum. These oral presentations should be of 10 minutes duration in related scientific track followed by 5 minutes question hour. Therefore, presenters are encouraged to give comprehensive and dynamic talks. Applications will be selected based on past research productivity and future promise.

Important dates

Conference dates

December 09-10, 2019

Early bird Registration

Aug 15, 2019

Abstract submission

Nov 20, 2019

 

Registration link: http://bioavailability-bioequivalence.alliedacademies.com/registration

Allied Academies is an established and reputed publisher which started publishing in the year 1994. The Allied Academics play a major role in imparting knowledge and keep one aware of the new trends in the different areas of study through journals and conferences. In this journey of publishing, the publisher received several awards and accolades for dedicated service and strictly considering ethical practices. Allied Academies has become an obvious choice for the researchers and academicians to showcase their excellent contributions. The publisher provides authors and readers with a complete platform to share their work with the global community.



Scientific Sessions

Session 1: Bioavailability

Bioavailability is a subcategory of retention and is the portion of managed measurements of unaltered medicine that achieves the imperative dissemination, one of the essential pharmacokinetic properties of medications. when a pharmaceutical is directed intravenously, its bioavailability is 100%. when a prescription is directed through one of a kind courses, (for example, orally), its bioavailability typically TH diminishes or may additionally shift from patient to quit. Bioavailability is one of the necessary units in pharmacokinetics, as bioavailability ought to be considered whilst ascertaining measurements for non-intravenous guides of the organization.

Session 2: Bioequivalence

Bioequivalence may be a term in pharmacology want to survey the conventional in vivo natural quotient of 2 restrictive arrangements of a medicine. within the event that 2 things are same to be bioequivalent it implies that they'd be needed to be, in each sensible sense, the same. 2 pharmaceutical things are bioequivalent on the off probability that they're pharmaceutically proportional associated their bioavailability once organization in an exceedingly similar molar activity are like such an extent, to the purpose that their belongings, concerning each viability and eudaemonia, are often relied upon to be primarily the identical. Pharmaceutical equality infers an identical live of a similar dynamic substance(s), in an exceedingly similar dose form, for an identical course of organization and meeting the identical or equal benchmarks.

 

Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

Session 3: Advances in Chromatography

The HPLC methodology applied to the analysis of biological samples makes it possible for the identification of many metabolites. Samples from two human embryos culture medium were analysed by high-pressure liquid chromatography–mass spectrometry (HPLC–MS). They work on the principle that many microorganisms have their own unique mass spectral signature based on the particular proteins and peptides that are present in the cells. Identification of unknown peaks in gas chromatography (GC-MS)-based discovery metabolomics is challenging and remains necessary to permit discovery of novel or unexpected metabolites that may allergic diseases processes and/or further our understanding of how genotypes relate to phenotypes. Here, we introduce two new technologies and advances in pharmaceutical analytical methods that can facilitate the identification of unknown peaks.

•           Protein Phosphorylation and Non-Covalent Interaction
•           Carbohydrates, Microbes and Biomolecule Analysis
•           Approaches in Glycoproteins and Glycans
•           Advances in Isolation, Enrichment and Separation
•           Structural Proteomics and Genomics
•           Nano scale and Micro scale Fluidic Separation
•           Lipidomic, Metabolomics and Ultrarace Analysis
•           Atom Probe Tomography

Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

Session 4: Biosimilars
 

A biosimilar (otherwise known as a innings biological or ensuant section biological) may be a biologic restorative item that's right around an indistinguishable duplicate of a singular item, with an identical dynamic substance, that's fictional by an alternate organization. Biosimilars are formally supported diversifications of distinctive "innovator" things and might be created once the primary item's patent terminates. Respect to the pioneer item is a necessary a part of the endorsement. Not in any respect like with nonspecific medications of a lot of typical very little atom compose, biologics, for the foremost half, show high sub-atomic complexity and may be terribly delicate to changes in collection forms. Yet that non uniformity, all biopharmaceuticals, as well as biosimilars, should maintain steady quality and clinical execution throughout their lifecycle.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences


Session 5: Pharmacovigilance

Pharmacovigilance (PV or PhV), otherwise referred to as drug safety, is that the medical specialty science distinctive with the build-up, location, appraisal, observing, and countervailing action of unfriendly impacts with pharmaceutical things. All things thought of, pharmacovigilance smartly centres around unfriendly medication responses, or ADRs, that are characterised as any reaction to a medicine which is harmful and causeless, as well as absence of effectuality (the condition that this definition simply applies with the measurements usually utilised for the bar, conclusion or treatment of complaint, or for the adjustment of physiological issue work was prohibited with the foremost recent correction of the suitable enactment). Prescription mistakes, as an example, overdose, and abuse and ill-treatment of a medicine and to boot sedate presentation amid maternity and breastfeeding, are likewise of intrigue, even while not Associate in Nursing antagonistic occasion, since they will lead to Associate in Nursing unfavourable medication response. Pharmacovigilance is disquieted regarding characteristic the hazards associated with pharmaceutical things and with limiting the danger of any harm that will come back to patients. Organizations should direct an intensive medication security and pharmacovigilance review to survey their consistency with overall laws, controls, and direction.


·         Adverse drug reaction

·         Pharmacovigilance process

·         Drug safety


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences


Business Management will be a multidisciplinary gathering and present of areas such as Business Management, Social Sciences, Economics, New Technology’s, Education and policies. The forum of Scientists, students and researchers from all over of the globe, come together to discuss about the future science & Technology. Each session of the conference will be included with expert lectures, poster and discussions, join us to design sustainable development processes, innovations by which and how these strategies drive new policies, advances the business and human health protection.

 

  • Brand Management
  • Family Firms
  • Open Innovation


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences | Business Management | Business Technology Management

Session 7: Business Technology Management

These deals with the Products and business models in today's competitive environment are increasingly being transformed by technology. This new digital economy places IT at the centre of firm strategy and operations, and requires a new breed of IT managers and leaders who can examine technology through a business lens. The Business Technology Management specialization will entitle you with the knowledge of the IT domain, management, leadership and team building skills, functional skills as well as analytical skills. These skills are critical to influence technology to create competitive advantage.


  • Innovation, Technology and Entrepreneurship
  • Creative Industries


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences Business Management Business Technology Management


Session 8: Entrepreneur Investment Meet

An individual who puts his or her own specific money in a pioneering association. At first, a term used to depict theorists on Broadway shows up, "holy messenger" presently insinuates any person who puts his or her money in an innovative association. (Co)founders are people related with the hidden dispatch of new organizations. Anyone can be a prime supporter, and a present association can moreover be a kindred sponsor, yet the most notable prime supporters are originator CEOs, engineers, software engineers, website specialists, site masters, and others connected with the ground dimension of another, routinely experience. Wound Care gives wonderful streets to Investors searching for endeavour openings and growing their business horizons. Our congress has individuals from in excess of forty countries and attracts an influencing mix of enlightening researchers, specialists, and people who have busy with different pieces of progressions in Wound Care and Regenerative Medicine examination thus giving heaps of frameworks organization openings and new information. 

 

·         Financial markets

·         Classical and neoclassical economists

·         Research and development efforts

·         Investment strategy

·         Types of financial investment


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences Business Management Business Technology Management


Session 9: Clinical Research

 

Clinical lookup is a section of social insurance science that decides the wellbeing and adequacy (viability) of prescriptions, gadgets, analytic gadgets and cure regimens proposed for human utilize. These might be utilized for anticipation, treatment, determination or for diminishing manifestations of a sickness. Clinical research is commonly related to scientific practice. In scientific practice built up drugs are utilized, whilst clinical lookup proof is gathered to build up a treatment. The expression “clinical research” alludes to the entire listing of sources of a medication biologic, indeed, any look at article from its starting place in the lab to the first experience with the patron advertise and past. Clinical lookup is frequently directed at scholarly restorative focuses and partnered observe ponder destinations. These focuses, and locales supply the glory of the scholarly organisation and additionally get admission to higher metropolitan zones, giving a bigger pool of therapeutic members. These scholarly restorative focuses commonly have their inward Institutional Review Boards that manipulate the ethical direct of medicinal research.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

 
Bioavailability and bioequivalence meeting are a phase to have all the coherent unmistakable over the globe. In pharmacology, bioavailability (BA) is a subcategory of ingestion and is the bit of a regulated estimation of unaltered medicine that achieves the principal stream, one of the basic pharmacokinetic properties of medications. Bioavailability is one of the huge mechanical gatherings in pharmacokinetics, as bioavailability must be viewed as when figuring measurements for non-intravenous courses of affiliation.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

 
 
Pharmacokinetics, in some instances truncated as PK, is a section of pharmacology dedicated to figuring out the future of materials managed to a residing life form. The elements of intrigue contain any concoction xenobiotic, for example, pharmaceutical medications, pesticides, sustenance brought substances, care products. Pharmacokinetics depicts how the body influences a unique xenobiotic/concoction after employer through the aspects of assimilation and circulation and in addition the metabolic adjustments of the substance in the body, and the influences and publications of discharge of the metabolites of the medication. Pharmacokinetic homes of artificial elements are influenced by means of the direction of agency and the size of the managed medication. These can also impact the ingestion rate. Pharmacodynamics (PD) is the investigation of the biochemical and physiologic impacts of medications, pharmaceutical medications. The influences can comprise those showed internal creatures (counting people), microorganisms, or blends of existence varieties (for instance, disease). Pharmacodynamics is the investigation of how a medicine influences a living being, even though pharmacokinetics is the investigation of how the residing being influences the medication. Both collectively influence dosing, advantage, and hostile impacts. Pharmacodynamics is in some instances shortened as PD and pharmacokinetics as PK, mainly in consolidated reference. The concept of pharmacodynamics has been prolonged to incorporate Multicellular Pharmacodynamics (MCPD). MCPD is the investigation of the static and dynamic homes and connections between an association of medicines and a dynamic and different multicellular four-dimensional association. It is the investigation of the workings of a medicine on a negligible multicellular system (MCS), each in vivo and in silico.

 

·         Drug clearance

·         Pharmacokinetics models

·         Volume of distribution

·         Half-life of drug

·         Dose-response relationship 


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences


Session 12: Drug Discovery
 
In the fields of medicine, biotechnology, and pharmacology, drug discovery is the manner by means of which new competitor tablets are found. Generally, drugs have been observed by using recognizing the dynamic fixing from time-honoured cures or by means of lucky disclosure. Later compound libraries of manufactured little particles, normal objects or concentrates have been screened in flawless cells or entire creatures to understand resources that have a therapeutic impact affect in a process recognized as classical hooked up pharmacology. Since the sequencing of the human genome which accredited quickly cloning and amalgamation of good sized amounts of refined proteins, it has grew to become out to be simple exercise to utilize excessive throughput screening of expansive mixes libraries in opposition to separated organic targets which are guessed to be malady changing in a system recognised as swap pharmacology. Hits from these screens are then tried in cells and after that in creatures for viability. 

 

·         Target validation

·         Biological target

·         Computer-aided drug design

·         Drug discovery tools


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

Session 13: Pharmaceutical Formulations

 

pharmaceutical formulation, in pharmaceutics, is the procedure in which distinctive concoction substances, including the active drug, are consolidated to create a last therapeutic item. The word definition is regularly utilized in a way that incorporates dose shape. Detailing thinks about include building up an arrangement of the medication which is both steady and worthy to the patient. For orally directed medications, this, as a rule, includes consolidating the medication into a tablet or a container. It is essential to make the refinement that a tablet contains an assortment of other conceivably idle substances separated from the medication itself, and studies must be done to guarantee that the typified tranquilize is perfect with these different substances in a way that does not cause hurt, regardless of whether immediate or circuitous. Pre-formulation includes the portrayal of a medication's physical, synthetic, and mechanical properties keeping in mind the end goal to pick what different fixings (excipients) ought to be utilized in the readiness.

 

·         Route of administration

·         Stages of pharmaceutical formulations

·         Polymorphism

·         Encapsulation


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

Session 14: Bioanalytical Chemistry

Bioanalytical chemistry is a sub discipline of analytical chemistry that includes the separation, detection, identification and quantification of biological samples in different settings. It often involves the study of molecules such as proteins, peptides, DNA and drugs. It is the bridge between biology and analytical process and it relies on the identification and characterization of particles and compounds, particularly those are involved with the life and health processes.

Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences


Session 15: Pharmaceutical Technology

Pharmaceutical technology utilizes scientific aspects and technology in pharmaceutical sectors. It consists of methods, techniques, and handling of instruments in the formulation, manufacture, packaging, and logistics of drugs and other techniques used in diagnostic and determinative procedures and in the medication procedures.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

Session 16: Regulatory Affairs

 

Administrative issues (RA), moreover called government issues, is a calling inside coordinated undertakings, for instance, pharmaceuticals, therapeutic gadgets, agrochemicals (plant confirmation things and fertilizers), imperativeness, dealing with a record, telecom, etc. Managerial endeavours also include an unquestionable significance inside the therapeutic administration’s undertakings (pharmaceuticals, helpful contraptions, biologics, and valuable sustenance’s). The regulatory limit in social protection organizations is fundamental in making ensured and convincing human administrations things available around the globe. Individuals who ensure managerial consistency and prepare sections, and moreover those whose essential business work is clinical issues or quality insistence are inside and out seen as authoritative specialists. Various in the Regulatory Affairs Profession trust the New Approach to control will, over the long haul, be grasped for every single therapeutic administration thing as it addresses the best model for passing on new human administrations advances to feature in a reasonable time with commendable security.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

 

Session 17: Biopharmaceutics

 

Biopharmaceutics looks at the interrelationship of the physical/chemical properties of the medication, the dose shape in which the medication is given, and the course of organization on the rate and degree of systemic drug absorption. The significance of the medication substance and the medication definition on assimilation, and in vivo circulation of the medication to the site of activity, is portrayed as an arrangement of occasions that go before elicitation of a medication's helpful impact. In the first place, the medication in its measurement shape is taken by the patient either by an oral, intravenous, subcutaneous, transdermal, and so forth, the route of administration. Next, the medication is discharged from the measurement shape in an anticipated and characterizable way. At that point, some portion of the medication is assimilated from the site of the organization into either the encompassing tissue, into the body (likewise with oral measurement shapes), or both. At long last, the medication achieves the site of activity.

 

·         Potency of drug products

·         Applied biopharmaceutics

·         Absorption of drug

·         Bioinformatics

·         Recent technology in biopharmaceutics

 

Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

Session 18: Drug Toxicity

 

Drug toxicity is the development of severe, drug-related complications, which may require withdrawal of a particular drug or dose reduction. The toxic effects of a drug are dose-dependent and can affect an entire system as in the CNS or a specific organ such as the liver. Drug toxicity usually occurs at doses that exceed the therapeutic efficacy of a drug, however, toxic and therapeutic effects can occur simultaneously. It can be assessed at the behavioral or physiological level. Behaviorally, drug toxicity can be exhibited in a variety of ways, for example, decreases in locomotor activity, loss of motor coordination, cognitive impairment. Examples of physiological effects include lesions to tissue, neuronal death, and disrupted hormonal cycles.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences


Session 19: Bioanalytical Methodology

 

The field of bioanalysis has improved significantly from early studies in drug metabolism by using many simple and advanced techniques. In today’s Bioanalyst it  is well equipped which can deal with the modern challenges. A bioanalytical method is a set of procedures which is  involved in the collection, processing, storage and analysis of a biological matrix for a chemical compound. Bioanlysis covers the quantitative measurement of Xenobiotics of drugs such as their metabolites, and biological molecules in unnatural locations or concentrations and Biotics like macromolecules, proteins, DNA, large molecule drugs, metabolites in biological systems. Bioanalysis is a sub-discipline of analytical chemistry covering the quantitative measurement of xenobiotics and biotics in biological systems. The main impact of bioanalysis in the pharmaceutical industry is to obtain a quantitative measure of the drug or its metabolites for the study of pharmacokinetics, toxicokinetics, bioequivalence and exposure-response like pharmacokinetic and pharmacodynamic studies.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

 

Session 20: Public Health Nutrition

Public health nutrition is the utilization of nourishment and general public health to configuration programs, frameworks, strategies, and conditions that intends to enhance or keep up the ideal soundness of populaces and focused on gatherings. The primary significance of this is eating an adjusted eating regimen is crucial for good wellbeing and prosperity. Sustenance gives our bodies the vitality, protein, fundamental fats, vitamins and minerals to live, develop and work appropriately. An undesirable eating regimen builds the danger of many eating routine related infections.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

 

Session 21: FDA In Bioequivalence

 

The Unites States Food and Drug administration (FDA) has defined bioequivalence as “the absence of a major distinction within the rate and extent to that the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes obtainable at the site of drug action when administered at the same molar dose under the similar conditions in an appropriately designed study.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence | Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences


Session 22: Pharmacology

Pharmacology: where a drug can be widely portrayed as any man-made, customary, or endogenous molecule which applies a biochemical or physiological effect on the cell, tissue, organ, or animal even more especially. It is the examination of the associations that occur between a living structure and engineered exacerbates that impact normal or unusual biochemical limit. In case substances have remedial properties, they are contemplated pharmaceuticals. Pharmacology has primary two sections, pharmacodynamics and pharmacokinetics. Pharmacodynamics considers the effects of a drug on natural structures, and Pharmacokinetics contemplates the effects of regular systems on a medicine.


Bioavailability and Bioequivalence Conferences | Conferences on Bioavailability | BABE Conferences | Congress on Bioavailability and Bioequivalence Pharmaceutical Conferences Asia | Bioavailability | Bioequivalence | Bioequivalence conferences | Pharmaceutical Congress | Clinical Research Conferences | Biopharmaceuticals Conferences

Market Analysis

Global market for generic drugs was worth $81 billion in 2008, a figure that is expected to reach $84 billion in 2009. In 2014, the market is expected to amount to $168.7 billion, for a compound annual growth rate (CAGR) of 15% in the 5-year period.The global market for generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021. Sales of U.S. generic drugs are currently dominate the market, estimated at $33 billion in 2009 and projected to increase at a CAGR of 10.4% to $54 billion in 2014. And the  Sales of generic drugs in Canada rose from $3.0 billion in 2006 to $5.5 billion in 2016 at a rate of growth similar to the other industrialized countries. And also Japan’s generic drugs market is expected to have the highest rate of growth among major markets at 12.2%, increasing from $5.4 billion in 2009 to $9.6 billion in 2014. Generic drugs are also considered to be 74% of the volume of drugs in the Canadian pharmaceutical market in 2016 which is the third highest among the OECD countries after the United States and Germany. Canadians spent $165 per capita on generic drugs in 2016 which is the second highest among the OECD countries after the United States.

 

 

 

Organizing Committee
OCM Member
Dr. Rudrarup Gupta
Researcher, MBA
NIM
Kolkata, India
OCM Member
Dr. Neetesh Kumar Jain
Principal and Professor, Department of Pharmacy
Oriental University
Indore, India
OCM Member
Dr. Swamy KB
Professor and HOD of Clinical Anatomy, Clinical Anatomy
Lincoln University
Lincoln, New Zealand
OCM Member
Abdeen Mustafa Omer
Researcher at Ministry of Health and Social Welfare
Ministry of Health and Social Welfare
Al-Gamaa Ave, Sudan
OCM Member
Dr. Christina Leung
optometrist licensed by the State Board of Optometry of California, optometrist
The University of California
California, USA
OCM Member
Dr. Burton M.Altura
Professor, Department of physiology, Pharmacology
SUNY Downstate Medical Center
New York, USA
OCM Member
Kate Fletcher
Head of Pharmacy, University of Reading Malaysia
University of Reading Malaysia
George Town, Malaysia
OCM Member
Francisco Lopez Munoz
Professor, Department of Pharmacology
Universidad Camilo Jose Cela
Madrid, Spain
OCM Member
Abdelrehim Mourad
Distinguished Professor, Dept. of Clinical Pharmacy
Misr University for Science and Technology
cairo, Egypt
OCM Member
Dr. Ian Martins
Edith Cowan University
Queensland, Australia
OCM Member
Jorge I. González Borroto
Senior Toxicologist & Nonclinical Safety Adviser
Ferrer Internacional
Barcelona, Spain
OCM Member
Dr. Nasir M. Idkaidek
Prof. Pharmaceutics & Assistant Dean, Biopharmaceutics and Pharmacokinetics
University of Petra, Jordan
Amman, Jordan
OCM Member
Henry M. Sobell
Professor, Chemistry and Molecular Biophysics
University of Rochester, USA
Los Angeles, USA
OCM Member
Stephen Amato
Faculty Director of Graduate Regulatory Affairs, Global regulatory affairs
Northeastern University
Boston, USA
Renowned Speakers

To Collaborate Scientific Professionals around the World

Conference Date December 9-10, 2019
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

Venue: 
Hawthorn Suites By Wyndham Abu Dhabi City Center, Abu Dhabi - United Arab Emirates

Registration Benefits:

Only Registration Includes:

  • Access to All Sessions
  • CPD accredited
  • Coffee break during the conference
  • 2 days breakfast during the conference
  • 2 days Lunch during the conference
  • Handbook & Conference Kit
  • Lunch during the conference
  • Certificate of Presentation
  • B2B meetings

Package A

  • Accommodation for 2 nights: December 09 & 10, 2019
  • Above all only registration benefits
  • Free access to Wi-Fi

Package B

  • Accommodation for 3 nights: December 09 & 10, 2019
  • Above all only registration benefits
  • Free access to Wi-Fi 

Book your Accommodation Now  
Click here for Registration 
For Discounts & Group registration
Contact: Gary Samuels (Program Manager)
babe@alliedglobalevents.com
Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program Manager
babecongress@alliedglobalevents.com
General Query
babe@alliedglobalevents.com
Sponsorship/Exhibition
sponsor@alliedglobalevents.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

The organizer holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, loss, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

Insurance

No insurance, of any kind, is included along with the registration in any of the events of the organization.

Transportation

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

Press/Media

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact 
babe@alliedglobalevents.com 
to request a personalized letter of invitation, if not received until one month before the scheduled date of the event.

All the bank charges applicable during refund will be deducted from the account of the participant.

Cancellation Policy

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com 

If due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Postponement of event

If due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to finance@alliedacademies.com.

Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of the conferences.

However, Registration cannot be transferred if intimated within 14 days of the respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on September 1st, 2018.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 Refund Policy:

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

·         Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.

·         Within 60-30 days of Conference: Eligible for 50% of payment Refund

·         Within 30 days of Conference: Not eligible for Refund

·         E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness of the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

 

 

Authorization Policy

Copyright © 2019-2020 Allied Academies, All Rights Reserved.